Article Text

Download PDFPDF
Letter
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
  1. Adria Nogueras1,
  2. Maria Isabel Chinchilla Fernández2,
  3. Fernando Martínez2,
  4. Faus Maria Jose2,
  5. José Manuel Martínez Sesmero3,4,
  6. José Luis Poveda Andrés3,5,
  7. Miguel Ángel Calleja3
  1. 1 Government Affairs and Market Access Department, Novartis Pharma Spain, Barcelona, Spain
  2. 2 Catedra de Atención Farmacéutica, Universidad de Granada Facultad de Farmacia, Granada, Spain
  3. 3 Spanish Society of Hospital Pharmacy, Madrid, Spain
  4. 4 Hospital Pharmacy, Hospital Clinico Universitario San Carlos, Madrid, Spain
  5. 5 Pharmacy, Hospital Universitario y Politécnico La Fe, Valencia, Spain
  1. Correspondence to Dr Maria Isabel Chinchilla Fernández, Catedra de Atención Farmacéutica, Universidad de Granada Facultad de Farmacia, Granada 18011, Spain; maribelchinchill{at}hotmail.com

Statistics from Altmetric.com

Pharmacists play a crucial role in the evaluation of the effectiveness of healthcare systems, as they are the only professionals who can measure mean health outcomes against the cost of medication use.1 Today, hospital pharmacists act as expert advisors in decision-making on the most cost-effective alternatives for medicines agencies or, locally, in hospital pharmacy commissions. Hospital pharmacists have also evaluated their own service. From the creation of pharmacy services until the last decade, various cost-effectiveness analyses have been conducted of pharmacy services.2–4 These analyses have aimed primarily to use economic impact as one of the main arguments in favour of the creation of pharmacy services within hospitals.

It can be concluded that, in general, the pharmacy model has been demonstrated to be also profitable, and it is implemented all over the world.

However, the evaluation of cost-effectiveness of hospital pharmacy services is based on interventions that included a full economic analysis but only performed in single centres or in isolated interventions in few kinds of drugs. But that profitability does not necessarily …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.